| Literature DB >> 35723322 |
Chan Song Jo1, Cheol Hwan Myung1, Yeo Cho Yoon2, Beom Hee Ahn2, Jin Woo Min3, Won Sang Seo2,3, Dong Hwan Lee4, Hee Cheol Kang2,3, Yun Hoe Heo5, Hyeong Choi5, In Ki Hong5, Jae Sung Hwang1.
Abstract
Extracellular vesicles, which are highly conserved in most cells, contain biologically active substances. The vesicles and substances interact with cells and impact physiological mechanisms. The skin is the most external organ and is in direct contact with the external environment. Photoaging and skin damage are caused by extrinsic factors. The formation of wrinkles is a major indicator of skin aging and is caused by a decrease in collagen and hyaluronic acid. MMP-1 expression is also increased. Due to accruing damage, skin aging reduces the ability of the skin barrier, thereby lowering the skin's ability to contain water and increasing the amount of water loss. L. plantarum suppresses various harmful bacteria by secreting an antimicrobial substance. L. plantarum is also found in the skin, and research on the interactions between the bacteria and the skin is in progress. Although several studies have investigated L. plantarum, there are only a limited number of studies on extracellular vesicles (EV) derived from L. plantarum, especially in relation to skin aging. Herein, we isolated EVs that were secreted from L. plantarum of women in their 20s (LpEVs). We then investigated the effect of LpEVs on skin aging in CCD986sk. We showed that LpEVs modulated the mRNA expression of ECM related genes in vitro. Furthermore, LpEVs suppressed wrinkle formation and pigmentation in clinical trials. These results demonstrated that LpEVs have a great effect on skin aging by regulating ECM related genes. In addition, our study offers important evidence on the depigmentation effect of LpEVs.Entities:
Keywords: Lactobacillus plantarum; exosome; extracellular vesicles (EVs); pigmentation; skin aging
Year: 2022 PMID: 35723322 PMCID: PMC8928950 DOI: 10.3390/cimb44020036
Source DB: PubMed Journal: Curr Issues Mol Biol ISSN: 1467-3037 Impact factor: 2.976
Each primer sequences and Tm information used in this study.
| Primer | Primer Sequence | Tm (°C) | |
|---|---|---|---|
| Actin | Forward | 5′—CATGAAGTGTGACGTGGACA—3′ | 58 °C |
| Reverse | 5′—CAGGGCAGTGATCTCCTTCT—3′ | ||
| COL1A1 | Forward | 5′—GACCTCAAGATGTGCCACTC—3′ | 58 °C |
| Reverse | 5′—CCAGTCTCCATGTTGCAGAA—3′ | ||
| MMP-1 | Forward | 5′—CCCAGCGACTCTAGAAACAC—3′ | 58 °C |
| Reverse | 5′—GCCTCCCATCATTCTTCAGG—3′ | ||
| Filaggrin | Forward | 5′—GCTGAAGGAACTTCTGGAAAAG—3′ | 62 °C |
| Reverse | 5′—GCCAACTTGAATACCATCAGAAG—3 | ||
Figure 1Quantitative data of L. plantarum ratio of skin of women in their (A,B) 20 s and (C,D) 50 s.
Figure 2Phylogenetic tree based on 16S rRNA gene sequences of Lactobacillus plantarum isolated from skin of women in their 20′s.
Figure 3Purification and characteristics of Lactobacillus plantarum-derived extracellular vesicles (LpEVs): (A) a representative frame from one of the LpEVs’ nanoparticle tracking analysis videos. The purified EVs were diluted 1:500 in distilled water; (B) the particle size and number of LpEVs determined by nanoparticle tracking analysis (NTA); (C) protein and particle concentration of LpEVs.
Figure 4Evaluation of the effects of LpEVs on MMP-1 mRNA expression levels using RT-PCR in CCD986sk: (A) cell Proliferation of LpEVs in CCD986sk dermal fibroblasts. Cell proliferation assays were performed on cells treated with LpEVs in a dose dependent manner (** p < 0.01); (B) the MMP-1 expression levels in CCD986sk after irradiation of UVA and treatment of LpEVs (* p < 0.05); (C) the elastase inhibitory activity was measured in a dose dependent manner in CCD986sk (** p < 0.01, *** p < 0.001).
Figure 5Evaluation of the effects of LpEVs on collagen, filaggrin, and HAS2 expression levels in CCD986sk: (A) collagen mRNA expression levels (* p < 0.05); (B) filaggrin mRNA levels (* p < 0.05, ** p < 0.01); (C) HAS2 protein levels in CCD986sk after 24h of treatment (* p < 0.05, ** p < 0.01).
Subject information of clinical trials.
| Subjects of Clinical Trials (IRB Number: KDRI-IRB-20936) * | |||
|---|---|---|---|
|
|
|
| |
| Female | 40’s | 50’s | Age 50 |
| n = 6 | n = 10 | ||
| Total n = 16 | |||
*: Each data partner obtained the necessary Institutional Review Board (IRB) approval or exemption.
Figure 6Evaluation of the effects of LpEVs on wrinkle formation: (A) eye-wrinkle improvement assessments in clinical trials; (B) epidermidis elasticity improvement results in clinical trials; and (C) Antera 3D image (Wrinkle: Small) from clinical trials.
Figure 7Evaluation of the effects of LpEVs on moisture contents and skin density: (A) skin moisture improving effects; (B) ultrasound images; and (C) a numerical graph of the skin density improvement rate.
Figure 8Evaluation of the effects of pigmentation reduction through image analysis (Mark Vu) with LpEVs in clinical trials: (A) Mark Vu image; (B) the numerical graph of the skin density improvement rate of (A); (C) degree of reduction in pigmentation in visual reading.
Figure 9The anti-aging effects of extracellular vesicles derived from Lactobacillus plantarum isolated from the skin of women in their 20s.